Cargando…

Tocilizumab: Blood stream infection of methicillin-susceptible Staphylococcus aureus and off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160411/ http://dx.doi.org/10.1007/s40278-021-96709-6

Ejemplares similares

Methylprednisolone/piperacillin/tazobactam: Off-label use and methicillin-sensitive Staphylococcus aureus (MSSA) infection: case report
Publicado: (2021)

The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England
por: Duerden, Brian, et al.
Publicado: (2015)

Methylprednisolone: Bacterial endocarditis secondary to methicillin-sensitive Staphylococcus aureus infection following off-label treatment: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Methicillin-sensitive Staphylococcus aureus costochondritis and chest wall abscess: case report
Publicado: (2022)

Tocilizumab: Staphylococcus aureus infection, vancomycin resistant Enterococcus infection, Acinetobacterbaumannii infection and urinary tract infection following off-label use: 4 case reports
Publicado: (2021)

Methylprednisolone/tocilizumab: Hospital acquired infective endocarditis secondary to Enterococcus faecalis and Methicillin-sensitive Staphylococcus aureus infection: 2 case reports
Publicado: (2020)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Dexamethasone: Pneumocystis jirovecii pneumonia and methicillin-resistant Staphylococcus aureus endocarditis following the off-label use: 2 case reports
Publicado: (2022)

Endocarditis caused by methicillin-susceptible Staphylococcus aureus with reduced susceptibility to vancomycin: a case report
por: Perazzi, Beatriz, et al.
Publicado: (2011)

Tocilizumab: Herpes zoster infection following an off label use: case report
Publicado: (2022)

Microbial Susceptibility and Plasmid Profiles of Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible S. aureus
por: Shahkarami, Fatemeh, et al.
Publicado: (2014)

Methicillin-Resistant and -Susceptible Staphylococcus aureus Infections in Dogs
por: Faires, Meredith C., et al.
Publicado: (2010)

Tocilizumab: Candidaemia and Off-label-use: 3 case reports
Publicado: (2020)

Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Publicado: (2020)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Tocilizumab: Neutropenia following off-label use: case report
Publicado: (2021)

Differentiating methicillin resistant and susceptible Staphylococcus aureus from ocular infections using photoacoustic labeling
por: Edgar, Robert H., et al.
Publicado: (2023)

Piperacillin/tazobactam/tocilizumab: Trichosporon asahii infection and off-label-use: case report
Publicado: (2021)

Tocilizumab: Bacterial and fungal infections during off label treatment: 2 case reports
Publicado: (2021)

Vancomycin Heteroresistance Is Associated with Reduced Mortality in ST239 Methicillin-Resistant Staphylococcus aureus Blood Stream Infections
por: van Hal, Sebastiaan J., et al.
Publicado: (2011)

Tocilizumab: Septic shock following off-label use: case report
Publicado: (2020)

Tocilizumab: Lobar pneumonia following off label use: case report
Publicado: (2020)

Tocilizumab: Bacterial superinfection following off-label use: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Disseminated strongyloidiasis and off-label use: case report
Publicado: (2020)

Tocilizumab: Anastomotic leakage following off label use: case report
Publicado: (2021)

Tocilizumab: Active tuberculosis following off label use: case report
Publicado: (2021)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021)

Tocilizumab: Lack of efficacy following off-label use: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
por: Lowe, Rachel Amanda, et al.
Publicado: (2017)

Methicillin-resistant and methicillin-susceptible community-acquired Staphylococcus aureus infection among children
por: Gomes, Renata Tavares, et al.
Publicado: (2013)

Prednisone/tocilizumab: Staphylococcus aureus bacteraemia and aortic valve endocarditis : case report
Publicado: (2021)

Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021)

Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus
por: Gern, Benjamin H., et al.
Publicado: (2018)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Tocilizumab: Various toxicities following an off-label use: 3 case reports
Publicado: (2020)

Methylprednisolone/tocilizumab: Intestinal perforation following off-label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ul5ugj84lsjq48qvql7i1lkmqh